Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001209191-22-002062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-05 | 2022-01-03 | RXRX | Doyle Ramona | Chief Medical Off | M - OptEx | $2.47 | +40.3K | 40.3K | New | +$99.6K |
| D | 2022-01-05 | 2022-01-03 | RXRX | Doyle Ramona | Chief Medical Off | M - OptEx | $0.00 | -40.3K | 709.7K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-01-03 | M | A | 40,322 | $2.47 | 40,322 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-03 | M | D | 40,322 | $0.00 | 709,678 | D | $2.47 · — to 2030-12-30 | 40,322 Class A Common Stock | (F2) Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. |